At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Enoxaparindrug
Likely dose
Enoxaparin 1.5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Once Daily Enoxaparin for Outpatient Treatment of Acute Deep Venous Thrombosis and/or Pulmonary Embolism
In Brief
A clinical study evaluating Enoxaparin for Deep Vein Thrombosis and Pulmonary Embolism. Completed, enrolled 40 participants across 1 site.
Detailed Summary
To investigate the efficacy and safety of once daily enoxaparin as a "bridge" to warfarin for the outpatient treatment of acute deep venous thrombosis or pulmonary embolism.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDeep Vein Thrombosis, Pulmonary Embolism
CountriesUnited States
CollaboratorsSanofi
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2006
First PostedDec 2006
Primary CompletionApr 2008
Study CompletionDec 2008
TodayJul 2026
First PostedDec 19, 2006
Enrollment StartMay 1, 2006
Primary CompletionApr 1, 2008
Study CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 19.5 years ago
Interventions
Enoxaparindrug
Patient takes 1.5 mg per kilogram, once daily, subcutaneous injections until INR is therapeutic, then medication is stopped.